Literature DB >> 28865794

Changes in glucosylceramide structure affect virulence and membrane biophysical properties of Cryptococcus neoformans.

Shriya Raj1, Saeed Nazemidashtarjandi2, Jihyun Kim3, Luna Joffe4, Xiaoxue Zhang3, Ashutosh Singh5, Visesato Mor5, Desmarini Desmarini6, Julianne Djordjevic7, Daniel P Raleigh3, Marcio L Rodrigues8, Erwin London3, Maurizio Del Poeta9, Amir M Farnoud10.   

Abstract

Fungal glucosylceramide (GlcCer) is a plasma membrane sphingolipid in which the sphingosine backbone is unsaturated in carbon position 8 (C8) and methylated in carbon position 9 (C9). Studies in the fungal pathogen, Cryptococcus neoformans, have shown that loss of GlcCer synthase activity results in complete loss of virulence in the mouse model. However, whether the loss of virulence is due to the lack of the enzyme or to the loss of the sphingolipid is not known. In this study, we used genetic engineering to alter the chemical structure of fungal GlcCer and studied its effect on fungal growth and pathogenicity. Here we show that unsaturation in C8 and methylation in C9 is required for virulence in the mouse model without affecting fungal growth in vitro or common virulence factors. However, changes in GlcCer structure led to a dramatic susceptibility to membrane stressors resulting in increased cell membrane permeability and rendering the fungal mutant unable to grow within host macrophages. Biophysical studies using synthetic vesicles containing GlcCer revealed that the saturated and unmethylated sphingolipid formed vesicles with higher lipid order that were more likely to phase separate into ordered domains. Taken together, these studies show for the first time that a specific structure of GlcCer is a major regulator of membrane permeability required for fungal pathogenicity.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cryptococcus; Fungi; Glucosylceramide; Infectious disease; Plasma membrane; Sphingolipid

Mesh:

Substances:

Year:  2017        PMID: 28865794      PMCID: PMC5637408          DOI: 10.1016/j.bbamem.2017.08.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta Biomembr        ISSN: 0005-2736            Impact factor:   3.747


  49 in total

1.  Calorimetric investigation of the complex phase behavior of glucocerebroside dispersions.

Authors:  E Freire; D Bach; M Correa-Freire; I Miller; Y Barenholz
Journal:  Biochemistry       Date:  1980-08-05       Impact factor: 3.162

2.  Urease inhibition by EDTA in the two varieties of Cryptococcus neoformans.

Authors:  K J Kwon-Chung; B L Wickes; J L Booth; H S Vishniac; J E Bennett
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

3.  Methylation of glycosylated sphingolipid modulates membrane lipid topography and pathogenicity of Cryptococcus neoformans.

Authors:  Arpita Singh; Haitao Wang; Liana C Silva; Chongzheng Na; Manuel Prieto; Anthony H Futerman; Chiara Luberto; Maurizio Del Poeta
Journal:  Cell Microbiol       Date:  2012-01-09       Impact factor: 3.715

4.  On the origin of sphingolipid/cholesterol-rich detergent-insoluble cell membranes: physiological concentrations of cholesterol and sphingolipid induce formation of a detergent-insoluble, liquid-ordered lipid phase in model membranes.

Authors:  S N Ahmed; D A Brown; E London
Journal:  Biochemistry       Date:  1997-09-09       Impact factor: 3.162

5.  Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans.

Authors:  G M Cox; H C McDade; S C Chen; S C Tucker; M Gottfredsson; L C Wright; T C Sorrell; S D Leidich; A Casadevall; M A Ghannoum; J R Perfect
Journal:  Mol Microbiol       Date:  2001-01       Impact factor: 3.501

6.  Increased cerebroside concentration in plasma and erythrocytes in Gaucher disease: significant differences between type I and type III.

Authors:  O Nilsson; G Håkansson; S Dreborg; C G Groth; L Svennerholm
Journal:  Clin Genet       Date:  1982-11       Impact factor: 4.438

7.  Monoclonal antibody based ELISAs for cryptococcal polysaccharide.

Authors:  A Casadevall; J Mukherjee; M D Scharff
Journal:  J Immunol Methods       Date:  1992-09-18       Impact factor: 2.303

8.  The sphingolipid pathway regulates Pkc1 through the formation of diacylglycerol in Cryptococcus neoformans.

Authors:  Lena J Heung; Chiara Luberto; Allyson Plowden; Yusuf A Hannun; Maurizio Del Poeta
Journal:  J Biol Chem       Date:  2004-03-10       Impact factor: 5.157

9.  The discovery of australifungin, a novel inhibitor of sphinganine N-acyltransferase from Sporormiella australis. Producing organism, fermentation, isolation, and biological activity.

Authors:  S M Mandala; R A Thornton; B R Frommer; J E Curotto; W Rozdilsky; M B Kurtz; R A Giacobbe; G F Bills; M A Cabello; I Martín
Journal:  J Antibiot (Tokyo)       Date:  1995-05       Impact factor: 2.649

10.  Separation of liquid phases in giant vesicles of ternary mixtures of phospholipids and cholesterol.

Authors:  Sarah L Veatch; Sarah L Keller
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

View more
  17 in total

Review 1.  Report of the 12th Sphingolipid Club Meeting, Trabia, Italy (Sept. 7-10, 2017).

Authors:  Thierry Levade; Riccardo Ghidoni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-12-23       Impact factor: 3.000

2.  The putative flippase Apt1 is required for intracellular membrane architecture and biosynthesis of polysaccharide and lipids in Cryptococcus neoformans.

Authors:  Juliana Rizzo; Ana C Colombo; Daniel Zamith-Miranda; Vanessa K A Silva; Jeremy C Allegood; Arturo Casadevall; Maurizio Del Poeta; Joshua D Nosanchuk; James W Kronstad; Marcio L Rodrigues
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-12-29       Impact factor: 4.739

3.  Analysis of sphingolipids, sterols, and phospholipids in human pathogenic Cryptococcus strains.

Authors:  Ashutosh Singh; Andrew MacKenzie; Geoffrey Girnun; Maurizio Del Poeta
Journal:  J Lipid Res       Date:  2017-08-15       Impact factor: 5.922

Review 4.  Mechanisms of Pulmonary Escape and Dissemination by Cryptococcus neoformans.

Authors:  Steven T Denham; Jessica C S Brown
Journal:  J Fungi (Basel)       Date:  2018-02-17

5.  Acylhydrazones as Antifungal Agents Targeting the Synthesis of Fungal Sphingolipids.

Authors:  Cristina Lazzarini; Krupanandan Haranahalli; Robert Rieger; Hari Krishna Ananthula; Pankaj B Desai; Alan Ashbaugh; Michael J Linke; Melanie T Cushion; Bela Ruzsicska; John Haley; Iwao Ojima; Maurizio Del Poeta
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

Review 6.  Role of lipid transporters in fungal physiology and pathogenicity.

Authors:  Juliana Rizzo; Lyubomir Dimitrov Stanchev; Vanessa K A da Silva; Leonardo Nimrichter; Thomas Günther Pomorski; Marcio L Rodrigues
Journal:  Comput Struct Biotechnol J       Date:  2019-09-04       Impact factor: 7.271

7.  Regulation of sphingolipid synthesis by the G1/S transcription factor Swi4.

Authors:  Gabriel S Matos; Juliana B Madeira; Caroline Mota Fernandes; Deveney Dasilva; Claudio A Masuda; Maurizio Del Poeta; Monica Montero-Lomelí
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2021-05-29       Impact factor: 5.228

Review 8.  Peeling the onion: the outer layers of Cryptococcus neoformans.

Authors:  Daniel P Agustinho; Liza C Miller; Lucy X Li; Tamara L Doering
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-05-07       Impact factor: 2.743

Review 9.  Biological Roles Played by Sphingolipids in Dimorphic and Filamentous Fungi.

Authors:  Caroline Mota Fernandes; Gustavo H Goldman; Maurizio Del Poeta
Journal:  mBio       Date:  2018-05-15       Impact factor: 7.867

10.  Sterol-Response Pathways Mediate Alkaline Survival in Diverse Fungi.

Authors:  Hannah E Brown; Calla L Telzrow; Joseph W Saelens; Larissa Fernandes; J Andrew Alspaugh
Journal:  mBio       Date:  2020-06-16       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.